(3aS,3a'S,8aR,8a'R)-2,2'-(Cyclopropane-1,1-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole), 98.0%, 250mg

Vasos de muestra con cierre de rosca con área de graduación y etiquetado, 120 ml, No estéril, 500 Unidad(es)

3-Aminopyridine, 99.0%, 10g

4-Methylquinoline-2-carbonitrile, 97%, 250mg

6-BROMO-3-METHYL-1-(TETRAHYDRO-2H-PYRAN-2-YL)-1H-INDAZOLE, 95.0%, 5g

1,5-Diphenylcarbazide, 95.0%, 100g

(1S,7S)-4-Dimethylamino-9,9-dimethyl-2,2,6,6-tetrakis(3,5-dimethylphenyl)-3,5,8,10-tetraoxa-4-phosphabicyclo[5.3.0]decane, 95%, 1g

tert-butyl N-[4-bromo-2-(trifluoromethyl)phenyl]carbamate, 98%, 25g

2,4-Dichloro-6-methylpyrimidine, 96.0%, 1g

2-Amino-6-methoxyphenol hydrochloride, 95.0%, 5g

3,3-Dimethyl-piperazin-2-one, 95.0%, 5g

((4-Iodophenyl)ethynyl)trimethylsilane, 95.0%, 10g

3-Amino-6-bromopyrazin-2(1H)-one, 95.0%, 10g